Does UBIDECARENONE Cause Therapeutic product effect incomplete? 113 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Therapeutic product effect incomplete have been filed in association with UBIDECARENONE (CO Q 10). This represents 31.3% of all adverse event reports for UBIDECARENONE.
113
Reports of Therapeutic product effect incomplete with UBIDECARENONE
31.3%
of all UBIDECARENONE reports
0
Deaths
105
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From UBIDECARENONE?
Of the 113 reports, 105 (92.9%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UBIDECARENONE. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does UBIDECARENONE Cause?
Drug ineffective (130)
Headache (125)
Pain (125)
Malaise (115)
Off label use (114)
Nausea (113)
Abdominal pain (109)
Constipation (109)
Pyrexia (109)
Weight decreased (107)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which UBIDECARENONE Alternatives Have Lower Therapeutic product effect incomplete Risk?
UBIDECARENONE vs UBLITUXIMAB
UBIDECARENONE vs UBLITUXIMAB-XIIY
UBIDECARENONE vs UBROGEPANT
UBIDECARENONE vs ULIPRISTAL
UBIDECARENONE vs UMBRALISIB